159 related articles for article (PubMed ID: 11999678)
1. Comparison of the ocular comfort of ofloxacin 0.3% ophthalmic solution and lubricant eye drops.
Roberts C
Clin Pediatr (Phila); 2002 Apr; 41(3):151-4. PubMed ID: 11999678
[No Abstract] [Full Text] [Related]
2. A phase III clinical trial of 0.5% levofloxacin ophthalmic solution versus 0.3% ofloxacin ophthalmic solution for the treatment of bacterial conjunctivitis.
Schwab IR; Friedlaender M; McCulley J; Lichtenstein SJ; Moran CT;
Ophthalmology; 2003 Mar; 110(3):457-65. PubMed ID: 12623805
[TBL] [Abstract][Full Text] [Related]
3. [Problems on pharmaceutical treatment in ophthalmology].
Kirisawa N
Nippon Ganka Gakkai Zasshi; 1968 Oct; 72(10):1966-80. PubMed ID: 5751414
[No Abstract] [Full Text] [Related]
4. [Pharmaco-toxicological aspects of ophthalmological medication].
Cristea E
Rev Chir Oncol Radiol O R L Oftalmol Stomatol Ser Oftalmol; 1985; 29(2):135-40. PubMed ID: 3161128
[No Abstract] [Full Text] [Related]
5. Comparison of topical 0.3% ofloxacin with fortified tobramycin plus cefazolin in the treatment of bacterial keratitis.
Panda A; Ahuja R; Sastry SS
Eye (Lond); 1999 Dec; 13 ( Pt 6)():744-7. PubMed ID: 10707137
[TBL] [Abstract][Full Text] [Related]
6. Side effects of systemic drugs on the eye and of ophthalmic drugs on the body.
el-Naggar AM; Khalil S
Bull Ophthalmol Soc Egypt; 1972; 65(69):563-6. PubMed ID: 4666816
[No Abstract] [Full Text] [Related]
7. Severe arthropathy with ofloxacin in two cases of MDR tuberculosis.
Arora VK; Tumbanatham A
Int J Tuberc Lung Dis; 1998 Nov; 2(11):941-3. PubMed ID: 9848618
[No Abstract] [Full Text] [Related]
8. Safety evaluation of a new formulation of intravenous ofloxacin.
Stein GE
Drugs; 1995; 49 Suppl 2():497-8. PubMed ID: 8549414
[No Abstract] [Full Text] [Related]
9. [The safety of ofloxacin].
Postnikov SS; Semykin SIu; Efremenkova OV; Sokolov AV; Kapranov NI; Litvinov DV
Antibiot Khimioter; 1999; 44(10):20-1. PubMed ID: 10635417
[TBL] [Abstract][Full Text] [Related]
10. Drugs and the aging eye.
Dangel ME; Havener WH
Geriatrics; 1981 Mar; 36(3):133-40. PubMed ID: 7215803
[No Abstract] [Full Text] [Related]
11. Determination of ofloxacin in tear by HPLC-ESI-MS/MS method: comparison of ophthalmic drug release between a new mucoadhesive chitosan films and a conventional eye drop formulation in rabbit model.
Byrro RM; de Oliveira Fulgêncio G; da Silva Cunha A; César IC; Chellini PR; Pianetti GA
J Pharm Biomed Anal; 2012 Nov; 70():544-8. PubMed ID: 22673938
[TBL] [Abstract][Full Text] [Related]
12. Comparison of fluoroquinolones: cytotoxicity on human corneal epithelial cells.
Tsai TH; Chen WL; Hu FR
Eye (Lond); 2010 May; 24(5):909-17. PubMed ID: 19648900
[TBL] [Abstract][Full Text] [Related]
13. Ofloxacin monotherapy for the primary treatment of microbial keratitis: a double-masked, randomized, controlled trial with conventional dual therapy. The Ofloxacin Study Group.
Ophthalmology; 1997 Nov; 104(11):1902-9. PubMed ID: 9373124
[TBL] [Abstract][Full Text] [Related]
14. [Time course of changes in functional visual acuity and ocular wavefront aberration after instillation of ofloxacin gel-forming ophthalmic solution].
Yamamoto T; Hiraoka T; Oshika T
Nippon Ganka Gakkai Zasshi; 2011 Dec; 115(12):1094-100. PubMed ID: 22312814
[TBL] [Abstract][Full Text] [Related]
15. Comparison of 2 oral ofloxacin regimens for the treatment of bacteriuria in elderly subjects.
Zorbas P; Giamarellou H; Staszewska-Pistoni M; Petrikkos G; Grammatikou M; Dontas AJ
Drugs; 1995; 49 Suppl 2():384-6. PubMed ID: 8549370
[No Abstract] [Full Text] [Related]
16. Systemic and local tolerability of ophthalmic drug formulations. An update.
Hugues FC; Le Jeunne C
Drug Saf; 1993 May; 8(5):365-80. PubMed ID: 8099291
[TBL] [Abstract][Full Text] [Related]
17. Tear concentration and safety of levofloxacin ophthalmic solution 1.5% compared with ofloxacin ophthalmic solution 0.3% after topical administration in healthy adult volunteers.
Walters T; Rinehart M; Krebs W; Holdbrook M
Cornea; 2010 Mar; 29(3):263-8. PubMed ID: 20098307
[TBL] [Abstract][Full Text] [Related]
18. Immediate hypersensitivity to levofloxacin diagnosed through skin prick test.
González-Mancebo E; Fernández-Rivas M
Ann Pharmacother; 2004 Feb; 38(2):354. PubMed ID: 14742782
[No Abstract] [Full Text] [Related]
19. Comparison of systemic absorption between ofloxacin ophthalmic in situ gels and ofloxacin conventional ophthalmic solutions administration to rabbit eyes by HPLC-MS/MS.
Li J; Zhao H; Okeke CI; Li L; Liu Z; Yin Z; Zhuang P; Sun J; Wu T; Wang M; Li N; Pi J; Zhang Q; Zhang R; Ma L; Pang X; Liu Z; Zhang L; Fan L
Int J Pharm; 2013 Jun; 450(1-2):104-13. PubMed ID: 23612359
[TBL] [Abstract][Full Text] [Related]
20. Ocular surface damage by ophthalmic compounds.
Mantelli F; Tranchina L; Lambiase A; Bonini S
Curr Opin Allergy Clin Immunol; 2011 Oct; 11(5):464-70. PubMed ID: 21822131
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
